Patheon Signs Deals with Sanofi-Aventis

PharmaManufacturing.com
01/11/2010

TORONTO, Jan. 11 /PRNewswire-FirstCall/ - Patheon, a provider of drug development and manufacturing services, announced today that it has signed two 5-year manufacturing agreements with Sanofi-Aventis. These agreements, for products manufactured in Patheon's Swindon and Bourgoin facilities, extend the company's longstanding partnership with Sanofi-Aventis to provide high quality outsourced manufacturing services.

Wes Wheeler, Chief Executive Officer and President of Patheon Inc. said, "We are very pleased with the partnership we have developed with Sanofi-Aventis over the past 10 years. The agreements mark another milestone in our relationship which was initiated through site acquisition and enables our mission to offer world-class facilities and expertise, with an unwavering focus on service quality."

More content on this topic: